Abbott Laboratories logo

Abbott Laboratories (ABL)

Market Open
17 Nov, 16:35
XFRA XFRA
113. 02
+1.36
+1.22%
- Market Cap
36.49 P/E Ratio
2.2% Div Yield
465 Volume
4.44 Eps
111.66
Previous Close
Day Range
112.5 113.36
Year Range
104.08 134.14
Want to track ABL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 64 days

Summary

ABL trading today higher at €113.02, an increase of 1.22% from yesterday's close, completing a monthly increase of 5.06% or €5.44. Over the past 12 months, ABL stock gained 3.67%.
ABL pays dividends to its shareholders, with the most recent payment made on 17 hours ago. The next estimated payment will be in In 3 months on Feb 17, 2026 for a total of €0.50616.
The last earnings report, released on Oct 15, 2025, missed the consensus estimates by -1.3%. On average, the company has fell short of earnings expectations by -0.43%, based on the last three reports. The next scheduled earnings report is due on Jan 20, 2026.
Abbott Laboratories has completed 8 stock splits, with the recent split occurring on Jan 02, 2013.
The company's stock is traded on 16 different exchanges and in various currencies, with the primary listing on NYSE (USD).

ABL Chart

Why Is Abbott (ABT) Up 1.3% Since Last Earnings Report?

Why Is Abbott (ABT) Up 1.3% Since Last Earnings Report?

Abbott (ABT) reported earnings 30 days ago. What's next for the stock?

Zacks | 3 days ago
Goldman Sachs Says US Stocks Could Lag for 10 Years: 5 Strong Buy Value Dividend Ideas

Goldman Sachs Says US Stocks Could Lag for 10 Years: 5 Strong Buy Value Dividend Ideas

Goldman Sachs has projected that U.S. stocks will deliver lackluster returns over the next decade primarily due to two key factors: extreme market concentration and elevated valuations.

247wallst | 3 days ago
Investors Heavily Search Abbott Laboratories (ABT): Here is What You Need to Know

Investors Heavily Search Abbott Laboratories (ABT): Here is What You Need to Know

Zacks.com users have recently been watching Abbott (ABT) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Zacks | 1 week ago

Abbott Laboratories (ABL) FAQ

What is the stock price today?

The current price is €113.02.

On which exchange is it traded?

Abbott Laboratories is listed on NYSE.

What is its stock symbol?

The ticker symbol is ABL.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 2.2%.

What is its market cap?

As of today, no market cap data is available.

When is the next earnings date?

The next earnings report will release on Jan 20, 2026.

Has Abbott Laboratories ever had a stock split?

Abbott Laboratories had 8 splits and the recent split was on Jan 02, 2013.

Abbott Laboratories Profile

Medical - Devices Industry
Healthcare Sector
Robert B. Ford CEO
XFRA Exchange
US0028241000 ISIN
US Country
114,000 Employees
15 Oct 2025 Last Dividend
2 Jan 2013 Last Split
13 Jan 1978 IPO Date

Overview

Abbott Laboratories is a global healthcare company that engages in the discovery, development, manufacturing, and sale of a wide range of health care products. With its foundation laid in 1888, and headquartered in North Chicago, Illinois, the company has established a significant presence worldwide. Abbott operates across four main sectors: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices, catering to a diverse range of healthcare needs from generic pharmaceuticals to advanced medical devices.

Products and Services

Abbott Laboratories offers a comprehensive portfolio of products and services across various healthcare domains:

  • Generic Pharmaceuticals: Includes treatments for pancreatic exocrine insufficiency, irritable bowel syndrome, biliary spasm, intrahepatic cholestasis, depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease, vestibular vertigo, pain, fever, inflammation, migraine, anti-infective clarithromycin, influenza vaccine, and colon rhythm regulation products.
  • Diagnostic Products: Offers laboratory and transfusion medicine systems in areas such as immunoassay, clinical chemistry, hematology, and transfusion. Includes molecular diagnostics for DNA and RNA processing and detection of infectious agents, point-of-care systems, blood gas testing cartridges, rapid diagnostics, molecular point-of-care testing for several diseases, cardiometabolic tests, drug and alcohol tests, remote patient monitoring, consumer self-tests, and laboratory automation and informatics solutions.
  • Nutritional Products: Provides nutritional products for both pediatric and adult use, catering to the specific dietary needs of different age groups and health conditions.
  • Medical Devices: Offers a wide array of devices for the treatment of cardiovascular diseases, including rhythm management, electrophysiology, heart failure, vascular, and structural heart devices. Additionally, the company develops diabetes care products such as blood glucose monitoring systems, along with neuromodulation devices for managing chronic pain and movement disorders.

Contact Information

Address: 100 Abbott Park Road
Phone: 224 667 6100